<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> was administered to two patients with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) with a dramatic effect on the hematological findings </plain></SENT>
<SENT sid="1" pm="."><plain>The patients, 31- and 41-year-old females, were initially diagnosed as having <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and were initially treated with anabolic steroid and immunosuppressive therapy, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Sugar water and Ham tests turned positive at the start of <z:chebi fb="1" ids="4315">danazol</z:chebi> therapy in the former patient and after two months in the latter patient </plain></SENT>
<SENT sid="3" pm="."><plain>This drug produced a dramatic improvement in the <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> level and the platelet count and showed few side effects in the patients </plain></SENT>
<SENT sid="4" pm="."><plain>A possible mechanism of action of <z:chebi fb="1" ids="4315">danazol</z:chebi> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> is briefly discussed </plain></SENT>
</text></document>